These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34884997)

  • 21. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
    Menezes J; Acquadro F; Wiseman M; Gómez-López G; Salgado RN; Talavera-Casañas JG; Buño I; Cervera JV; Montes-Moreno S; Hernández-Rivas JM; Ayala R; Calasanz MJ; Larrayoz MJ; Brichs LF; Gonzalez-Vicent M; Pisano DG; Piris MA; Álvarez S; Cigudosa JC
    Leukemia; 2014 Apr; 28(4):823-9. PubMed ID: 24072100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of myelodysplastic syndromes (MDS): An update.
    Ganguly BB; Kadam NN
    Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
    Ding Y; Yang J; Lindsey K
    Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R; Kosmider O; Renneville A; Gelsi-Boyer V; Meggendorfer M; Morabito M; Berthon C; Adès L; Fenaux P; Beyne-Rauzy O; Vey N; Braun T; Haferlach T; Dreyfus F; Cross NC; Preudhomme C; Bernard OA; Fontenay M; Vainchenker W; Schnittger S; Birnbaum D; Droin N; Solary E
    J Clin Oncol; 2013 Jul; 31(19):2428-36. PubMed ID: 23690417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
    Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
    Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R; Nabell L; Borak S; Peker D
    Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
    Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blastic plasmacytoid dendritic cell neoplasm: A case report.
    Wang W; Li W; Jia JJ; Zheng Y; Wang H; Gao XM; Dong XY; Tian Q; Jing HL; Wang X; Xiao SX
    Oncol Lett; 2015 Mar; 9(3):1388-1392. PubMed ID: 25663917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.
    Tang Z; Tang G; Wang SA; Lu X; Young KH; Bueso-Ramos CE; Alvarado Y; Medeiros LJ; Khoury JD
    Mol Cytogenet; 2016; 9():23. PubMed ID: 26925167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention.
    Prochaska L; Dakhil C; Mathur S
    Clin Med Insights Case Rep; 2013; 6():201-4. PubMed ID: 24385715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
    Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
    Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.
    Stengel A; Baer C; Walter W; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    Blood Adv; 2021 Nov; 5(21):4426-4434. PubMed ID: 34570179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.
    Amitay-Laish I; Sundram U; Hoppe RT; Hodak E; Medeiros BC; Kim YH
    JAAD Case Rep; 2017 Jul; 3(4):310-315. PubMed ID: 28752118
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical characteristics of 6 patients with blastic plasmacytoid dendritic cell neoplasm].
    Han X; Ouyang MQ; Pei Q; Duan MH; Jiang XY; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):700-705. PubMed ID: 28954350
    [No Abstract]   [Full Text] [Related]  

  • 36. Blastic plasmacytoid dendritic cell neoplasm in children: A review of two cases.
    Deng W; Yang M; Kuang F; Liu Y; Zhang H; Cao L; Xie M; Yang L
    Mol Clin Oncol; 2017 Oct; 7(4):709-715. PubMed ID: 28856005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.
    Sapienza MR; Abate F; Melle F; Orecchioni S; Fuligni F; Etebari M; Tabanelli V; Laginestra MA; Pileri A; Motta G; Rossi M; Agostinelli C; Sabattini E; Pimpinelli N; Truni M; Falini B; Cerroni L; Talarico G; Piccioni R; Amente S; Indio V; Tarantino G; Brundu F; Paulli M; Berti E; Facchetti F; Dellino GI; Bertolini F; Tripodo C; Rabadan R; Pileri SA
    Haematologica; 2019 Apr; 104(4):729-737. PubMed ID: 30381297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
    Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of gene mutation spectra in younger and older Chinese acute myeloid leukemia patients and its prognostic value.
    Zhong WJ; Liu XD; Zhong LY; Li KB; Sun QX; Xu X; Wei T; Li QS; Zhu ZG
    Gene; 2021 Feb; 770():145344. PubMed ID: 33333221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary blastic plasmacytoid dendritic cell neoplasm: a US population-based study.
    Huang L; Wang F
    Front Oncol; 2023; 13():1178147. PubMed ID: 37251924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.